As President, John Rydall brings more than 34 years of executive leadership and technical expertise in the biopharmaceutical, life sciences, medical cannabis, and advanced manufacturing sectors. Throughout his career, he has helped start-ups, emerging growth companies, and established organizations navigate complex operational, regulatory, and commercialization challenges, delivering strategic solutions that drive business growth and operational excellence.

John is recognized for his leadership in operations management, strategic planning, technical due diligence, business and organizational development, product commercialization, and high-performing team development. He has extensive experience overseeing facility and manufacturing operations, process development and optimization, technology transfer, validation, contract manufacturing, and large-scale capital projects from concept through commissioning.

His technical expertise encompasses biologics, active pharmaceutical ingredients (APIs), parenteral products, blood-derived therapeutics, plasma protein therapies, aseptic processing, downstream processing, protein purification, and commercial-scale manufacturing. He is also a recognized Subject Matter Expert in the medical cannabis and hemp sectors, advising organizations on GMP compliance, quality systems, process scale-up, manufacturing operations, and facility design programs aligned with Canadian, U.S., and European regulatory requirements.

John possesses deep knowledge of cGMP and ISO quality systems, CMC regulatory support, and global compliance frameworks. He is also highly experienced in sterile, non-sterile, and hazardous pharmacy compounding standards, including USP <797>, USP <800>, and NAPRA Practice and Regulatory Standards. Combining strong business acumen with advanced interpersonal and communication skills, John is a trusted advisor to organizations seeking to accelerate growth, ensure regulatory compliance, and successfully bring innovative products and technologies to market.

With over 20 years of leadership in the pharmaceutical and life sciences sectors, Amanda Wright is a seasoned executive recognized for driving organizational growth and fostering collaboration across the industry. Most recently, she served as Executive Director of the Pharmaceutical Sciences Group (PSG) for the past eight years, where she led the organization with a clear mission: to support the growth of Canada’s drug and biologics manufacturing landscape. During her tenure, Amanda championed professional education and workforce development, helping to strengthen the capabilities of the skilled professionals who power the industry.

With an extensive background in Microbiology and a career specializing in quality systems and regulatory compliance, Amanda previously served as Head of Microbiology at a large drug testing facility in Toronto. In this role, she led technical teams of all sizes to achieve operational excellence while meeting rigorous regulatory standards.

Passionate about education and innovation, Amanda has contributed her expertise to several associations and academic advisory committees, including the Public Health Agency of Canada (PHAC) Allied Health Table during the COVID-19 pandemic, the Healthcare Businesswomen’s Association, and Toronto Metropolitan University’s (TMU) Life Science Talent Accelerator Program. She continues to champion knowledge sharing and leadership as a respected voice within Canada’s life sciences community.

Dr. Jean-Pierre Metabanzoulou is a solution-driven and passionate pharmaceutical executive with more than 31 years of experience in Regulatory Affairs, Chemistry Manufacturing & Controls (CMC), Quality, and Compliance. Throughout his distinguished career, he has successfully led cross-functional teams, developed regulatory strategies, and directed product development programs across a diverse range of pharmaceutical and biopharmaceutical modalities—from early-stage development through late-stage clinical trials and post-approval lifecycle management.

With deep expertise in global regulatory environments, Dr. Metabanzoulou specializes in defining strategic regulatory pathways that accelerate product development, optimize submission success, and support commercialization objectives. His extensive experience spans CMC development, regulatory submissions, quality change controls, efficacy and safety updates, and interactions with global health authorities.

Dr. Metabanzoulou has built a proven track record of delivering successful outcomes across multiple therapeutic areas, including cardiometabolic diseases, oncology, vaccines, infectious diseases, neurology, pain management, and rare diseases. His strategic insight and hands-on leadership enable clients to navigate complex regulatory challenges with confidence while advancing innovative therapies from development to market.

"Flora Noitsis is a highly accomplished Quality & Compliance professional with more than 35 years of experience specializing in Good Manufacturing Practices (GMP) and Good Clinical Practices (GCP) compliance. Recognized for her regulatory expertise, collaborative leadership, and practical approach to compliance, Flora brings a unique perspective gained through over three decades of service as a Compliance Officer with Health Canada.

During her 31-year tenure at Health Canada, Flora played a critical role in safeguarding public health by ensuring that safe, effective, and high-quality products were available to Canadian patients. Her extensive regulatory experience spans pharmaceutical manufacturing, clinical research, laboratory operations, distribution, and quality systems oversight. Throughout her career, she has provided technical guidance and compliance support to manufacturers, packagers, sponsors, clinical research organizations (CROs), importers, distributors, laboratories, clinical researchers, and regulatory colleagues.

Flora is known for her ability to interpret complex regulatory requirements and translate them into practical, risk-based solutions that help organizations strengthen compliance, improve operational effectiveness, and maintain inspection readiness."

Angela Matsoukas is a seasoned quality and manufacturing professional with more than 30 years of experience across the pharmaceutical, biologics, clinical research, food, and dairy industries. Her extensive background spans quality control, sterile injectables manufacturing, quality management, and operational leadership, making her a trusted advisor for organizations operating in highly regulated environments.

Beginning her career as a microbiologist in a quality control laboratory, Angela steadily advanced through positions of increasing responsibility, culminating in executive leadership roles, including Vice President of Production Operations. This progression provided her with firsthand expertise in aseptic manufacturing, contamination control, facility design, process optimization, and quality systems management.

As a Senior Associate, Angela partners with clients to strengthen quality cultures, improve compliance programs, and implement practical, risk-based solutions that support both operational excellence and regulatory success.